The committee's chairwoman Carolyn Maloney called McKinsey's actions 'egregious' and said the company needs to answer for its actions.
McKinsey acknowledged in its statement that some staff members consulted for opioid makers and the FDA simultaneously, but added that its consulting work for the FDA wasn't drug-related.
"McKinsey's work for the FDA has focused on administrative and operational topics, including improvements to organizational structures, business processes and technology," the statement read."We have not advised the FDA on regulatory decisions or on specific pharmaceutical products."In its statement, McKinsey added that it plans to cooperate with the House committee to address any additional questions.
The report found that McKinsey completed 76 consulting contracts with the FDA between 2008 and 2022, which netted the company $140 million. Between 2004 and 2019, McKinsey completed 75 contracts with Purdue Pharma or its affiliates, according to the report. Some of the McKinsey staffers who consulted for both the FDA and Purdue Pharma included senior consultants Navjot Singh and Jeff Smith, the report found.
The committee report also states that McKinsey tried to convince opioid manufacturers on three separate occasions — through email and in-person presentations — to sign up for additional consulting contracts centered on increasing sales of opioids. In one incident in 2009, McKinsey gave a slide presentation pitching its capabilities to a group of drug manufacturers. In a bullet point detailing its experience McKinsey states that it has"Supported regulatory bodies directly, and as such has developed insights into the perspectives of the regulators themselves."America's Opioid Epidemic
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trial opens in Florida opioid lawsuit case against WalgreensIn Florida, the state's case hinges on accusations that as Walgreens dispensed more than 4.3 billion total opioid pills across 15 years.
Read more »
Where do US opioid trials and settlements stand?The effort to hold drug companies, pharmacies and distributors accountable for their role in the opioid crisis has led to a whirlwind of legal activity that can be difficult keep tabs on.
Read more »
Alaska’s fatal overdoses surged last year, a spike driven by fentanylThe Alaska Department of Health and Social Services will hold a workshop Thursday on using strips to detect the powerful synthetic opioid.
Read more »
Epidemiologist: Drug supply fueled WVa crisis over povertyAn epidemiologist testifying at West Virginia's ongoing trial against three major pharmaceutical companies said the influx of prescription opioids into communities was the main driver of the state’s drug crisis.
Read more »
Opioid overdose deaths among teens have skyrocketed due to fentanylOverdose deaths in adolescents rose far more rapidly than the general population between 2019 and 2021 because of fentanyl, according to a new study of CDC data.
Read more »